Home > Compound List > Product Information
Succinylcholine_Molecular_structure_CAS_306-40-1)
Click picture or here to close

Succinylcholine

Catalog No. DB00202 Name DrugBank
CAS Number 306-40-1 Website http://www.ualberta.ca/
M. F. C14H30N2O4++ Telephone (780) 492-3111
M. W. 290.399 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 87

SYNONYMS

IUPAC name
trimethyl[2-({4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl}oxy)ethyl]azanium
IUPAC Traditional name
succinylcholine
Brand Name
Quelicin Preservative Free
Anectine
Quelicin
Sucostrin
Synonyms
Scoline
Succinylcholine Chloride
Suxamethonium chloride

DATABASE IDS

CAS Number 306-40-1
PubChem CID 5314
PubChem SID 46506023

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
Indication Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)
Pharmacology Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine is a depolarizing skeletal muscle relaxant. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the receptor site. Succinylcholine has no direct action on the uterus or other smooth muscle structures.
Affected Organisms
Humans and other mammals
Biotransformation By pseudocholinesterase, to succinylmonocholine and choline.
Elimination About 10% of the drug is excreted unchanged in the urine.
References
Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. [Pubmed]
External Links
Wikipedia
RxList
Drugs.com

REFERENCES

  • Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. Pubmed